Status:
COMPLETED
The Long-term Course of Moderate Tricuspid Regurgitation
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Tricuspid Regurgitation
Heart Failure
Eligibility:
All Genders
18-95 years
Brief Summary
To evaluate the long-term clinical outcome of a cohort of patients suffering from moderate tricuspid regurgitation (TR), regardless of its etiology.
Eligibility Criteria
Inclusion
- Patients with an echocardiographic diagnosis of moderate TR
- Patients with echocardiographic and clinical follow-up information available at least 6-months after moderateTR diagnosis.
Exclusion
- Absence of an appropriate clinical and echocardiographic follow-up
- A history of previous TV intervention (either surgical or percutaneous)
- The presence of concomitant TV stenosis
- Congenital heart disease
- Left ventricular assist devices
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06169345
Start Date
May 1 2021
End Date
February 1 2023
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italy, 20900